Navigation Links
InVitria Headlines Sponsorship of WilBio's Waterside Conference

Supplier of high performance cell culture media components will reveal significant advantages of its products at the 14th International Meeting of The Waterside Conference, April 20-22 in San Francisco.

Fort Collins, CO (PRWEB) April 9, 2009 -- InVitria's line of high performance cell culture media components used for mammalian cell culture will be showcased at the upcoming Williamsburg BioProcessing Foundation The Waterside Conference on April 20-22, 2009, in South San Francisco.

Regarded as one of the leading events addressing scale-up and production issues facing the bioprocessing industry, the 2009 Waterside Conference comes at an opportune time for InVitria to share its product advantages with commercial biomanufacturers.

InVitria's Cellastim (recombinant human serum albumin) and Lacromin (recombinant Lactoferrin) have been used by large-scale commercial manufacturers to significantly improve CHO cell growth and productivity. Cellastim also increases hybridoma cell growth and monoclonal antibody production.

InVitria's Director of Cell Culture, Dr. Steve Pettit, will present two posters at the conference revealing the optimization benefits of InVitria's Cellastim in CHO and hybridoma cell lines. "Recent research from our own work and that of customers shows substantial improvements in the speed of cell line development and seed-train expansion using InVitria's recombinant product," said Dr. Pettit. "This is especially important for our customers who want to eliminate animal-derived components and also expedite their product development process," he continued.

"We are glad to partner with WilBio as a sponsor for this industry-leading event," commented Scott Deeter, InVitria President and CEO. "At The Waterside Conference, we invite existing and new customers to visit our booth to learn how InVitria can help you optimize productivity, reduce product development time and achieve your regulatory objectives."

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research and diagnostics.

For more information about InVitria's products, please contact us by e-mail or phone.

E-mail: info(at)InVitria(dot)com
Phone: 1-800-916-8311


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Announces Launch of Recombinant Albumin for Diagnostics
2. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
3. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
4. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
5. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
6. InVitria to Present at WilBio's International Cell Engineering Meeting
7. Oprah Show Expert and RealAge Cofounder Headlines ePharma Talk
8. Good News in Africa: Beyond the headlines
9. Fitness Model / Entrepreneur Targets Childhood Obesity and Makes Headlines Nationwide With New Franchise Offering
10. NHS Choices Launches Medical News Guide to What Lies Behind the Headlines
11. THE Aesthetic Show Attracts Record Sponsorship
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: